Skip to main content

and
  1. No Access

    Article

    R-Deprenyl: Pharmacological Spectrum of its Activity

    Deprenyl has been discovered by Knoll and co-workers. The R-enantiomer of deprenyl (selegiline) is a selective and irreversible inhibitor of the B-isoform of monoamine oxidase (MAO-B) enzyme. Due to its dopamine ...

    K. Magyar, B. Szende, V. Jenei, T. Tábi, M. Pálfi, É. Szökő in Neurochemical Research (2010)

  2. Article

    Open Access

    Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma

    A novel somatostatin analogue, TT-232 (which inhibits the proliferation of various cell cultures and transplantable mouse tumours), was examined regarding its effect on human melanoma and lymphoma xenografts a...

    B Szende, A Horváth, G Bökönyi, G Kéri in British Journal of Cancer (2003)

  3. Article

    Open Access

    Antitumor effect of lysine-isopeptides

    Isopeptides (ε-peptides) of lysine, with a given Mw and low polydispersity (10–400 units), were synthesized to study the relationship between their chemical structure and biological effect. The designed compou...

    B Szende, Gy Szökán, E Tyihá, K Pál, R Gáborjányi, M Almás in Cancer Cell International (2002)

  4. Article

    Open Access

    Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

    Insulin-like growth factors (IGFs) I and II are implicated in progression of various tumours including colorectal carcinomas. To interfere with the production of IGFs, we treated male nude mice bearing xenogra...

    K Szepeshazi, A V Schally, K Groot, P Armatis, G Halmos in British Journal of Cancer (2000)

  5. No Access

    Chapter

    The Neuroprotective and Neuronal Rescue Effect of (-)-Deprenyl

    (-)-Deprenyl treatment is able to increase the dopaminergic tone in the CNS by several mechanisms. It inhibits the normal metabolic degradation of dopamine and the metabolites formed from the drug reduce the u...

    K. Magyar, B. Szende in Apoptosis and Its Modulation by Drugs (2000)

  6. No Access

    Article

    Modification of pathobiological events by potential hepatopharmacological agents

    The elucidation of the pathobiological events in chronic liver diseases-such as cellular injury, cell proliferation, remodelling of extracellular matrix — has considerable importance for establishing the ratio...

    A. Jeney, I. Kovalszky, F. Timár, Zs. Schaff, A. Zalatnai, K. Lapis in InflammoPharmacology (1997)

  7. No Access

    Chapter

    Modification of Pathobiological Events by Potential Hepatopharmacological Agents

    The elucidation of the pathobiological events in chronic liver diseases — such as cellular injury, cell proliferation, remodelling of extracellular matrix — has considerable importance for establishing the rat...

    A. Jeney, I. Kovalszky, F. Timár, Zs. Schaff in Biochemical Pharmacology as an Approach to… (1997)

  8. No Access

    Article

    Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats

    The possible protective effect of an agonist of luteinising hormone-releasing hormone (LH-RH) against the ovarian damage caused by cyclophosphamide was investigated in rats. D-Trp6-LH-RH microcapsules were inj...

    L Bokser, B Szende, AV Schally in British Journal of Cancer (1990)

  9. No Access

    Article

    The effect of E-N-l-trimethyllysine (TML) on the humoral and cellular immune response

    E-N-l-Trimethyllysine glutamate (TML) influences the humoral and cellular immune response of mice. Chronic pre- and post-treatment (100 mg/kg/day, 5 times) transitionally increased the anti-SRBC haemagglutinin t...

    G. Elek, I. Láng, B. Szende, K. Lapis in Agents and Actions (1982)

  10. No Access

    Chapter

    Theoretical Bases for Designing Combination Therapy with Dibromodulcitol (DBD)

    From the results of clinical and experimental tumour chemotherapy it seems that no single agent seems to be able to deal effectively with most of the human tumours and reasonable therapeutic results can only b...

    K. Lapis, A. Jeney, L. Kopper, B. Szende, J. Takacs in Chemotherapy (1976)

  11. No Access

    Article

    A Transferable “Resistance Factor” from in vitro Cultured MDMS-Resistant Yoshida Sarcoma Cells

    Cells of the methylene dimethanesulphonate-(MDMS)-resistant Yoshida sarcoma cell line contain a low molecular weight “resistance factor” which is present in the culture medium of these cells and may be utilize...

    B Szende, M Fox, B W Fox in British Journal of Cancer (1973)